⌘K

Login Start Free

Home/Filings/4/0001209191-15-072330

4//SEC Filing

Oncothyreon Inc. 4

Accession 0001209191-15-072330

CIK 0001412067operating

View on SEC.gov Company Profile

Filed

Sep 27, 8:00 PM ET

Accepted

Sep 28, 5:36 PM ET

Size

5.6 KB

Accession

0001209191-15-072330

Insider Transaction Report

Form 4

Period: 2015-09-24

Oncothyreon Inc.ONTY

KIRKMAN ROBERT L

DirectorPresident/CEO

Transactions

Award
Stock Option (right to buy)
2015-09-24+750,000→ 750,000 total
Exercise: $3.51Exp: 2023-09-24→ Common Stock (750,000 underlying)

Footnotes (1)

[F1]The option vests and is exercisable at the rate of 1/4th of the total shares on September 24, 2016 and then 1/48th of the total shares vest and are exercisable monthly thereafter, with 100% vested and exercisable on September 24, 2019.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Oncothyreon Inc.

CIK 0001412067

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001412067

Filing Metadata

Form type: 4
Filed: Sep 27, 8:00 PM ET
Accepted: Sep 28, 5:36 PM ET
Size: 5.6 KB

View on SEC.gov